StageCorporate Majority | Acquired
On April 20th, 2022, Bloomage BioTech acquired a majority stake in Yierkang for $36.44M. Yierkang is a modern state-level high-tech enterprise integrating scientific research, production, and sales. The company provides collagen medical terminal products, including collagen sponges and artificial bone. The company was founded in 1997 and is based in Beijing, China.
Missing: Yierkang's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Yierkang's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Yierkang Frequently Asked Questions (FAQ)
When was Yierkang founded?
Yierkang was founded in 1997.
Where is Yierkang's headquarters?
Yierkang's headquarters is located at No. 9, Jinyuan Road, Industrial Development Zone, Beijing.
What is Yierkang's latest funding round?
Yierkang's latest funding round is Corporate Majority.
Who are the investors of Yierkang?
Investors of Yierkang include Bloomage BioTech.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.